8/4/2019 NILA One Pager

1/2

Ensuring Access to Laboratory Services for Medicare Beneficiaries

Clinical Laboratories: Weve Bled Enough Already

While less than 2 percent of all Medicare spending, clinical laboratory testing has been subject to

significant freezes in payments and cuts over the last decade:

Medicare payment amounts for clinical laboratory services have been reduced by about

40 percent in real (inflation-adjusted) terms over the past 20 years.

The Patient Protection and Affordable Care Act (PPACA) included a direct and immediate

cut to the Medicare Clinical Laboratory Fee Schedule of 1.75% each year for 5 years. This

9% cut is the largest cut among all Part B providers.

In PPACA, clinical laboratories also received another cut through the productivity

adjustment one of only a few providers subject to an immediate adjustment in 2011

resulting in an additional 11% cut over 10 years.

The laboratory-specific cut and the productivity adjustment will result in a cumulative 20%

cut over 10 years.

In some independent clinical laboratories, especially those serving rural communities or

nursing home populations, 80% or more of their patient-base consists of Medicare

beneficiaries. The cuts being faced threaten their practices existence and no additionalcuts big or small can be absorbed without adversely impacting patient care.

Clinical Laboratory Services: Critical for Patient Care and Health Outcomes

Though a small percent of Medicare revenue is spent on clinical laboratory testing, it is

estimated that clinical laboratory tests inform up to 70 percent of doctors medical

decision-making.

As the first point of intervention, laboratory tests serve as the foundation for the diagnosis

and clinical management of conditions like heart disease, cancer, diabetes, kidney disease,

and infectious diseases.

Medicare beneficiaries in nursing homes rely upon the services provided by independent

clinical laboratories that can deploy medical professionals to their place of residence.

On-site blood draw services for a non-ambulatory patient save the patient the trip (often

via ambulance) to a hospital or laboratory draw center, potentially reducing costs and

avoiding travel-related clinical risks for such patients.

8/4/2019 NILA One Pager

2/2

Clinical Laboratory Coinsurance: Co-pay = No pay

There is currently no cost sharing for clinical laboratory tests paid for under Medicare Part B. Cost

sharing for laboratory services has been rejected by Congress multiple times over the past ten years,

most recently during health reform. Cost sharingwhether a uniform coinsurance or a direct co-pay

for beneficiarieswould have a negative consequence for patients and the providers that performtheir laboratory testing:

Lab and patient interaction is minimal. Most labs collect specimens from a doctors office

or other health care facility, meaning that billing for lab co-pays would happen after the

testing is done and without ever directly interacting with the patient.

Laboratories would have to generate approximately 214 million new bills each year to

seniors and attempt to collect from them.

According to the Institute of Medicine, it costs a lab about $5.00 to send a bill to a patient

to collect a co-pay.

1

In most cases a this co-pay would be impossible to collect. The cost of collecting the co-pay would almost always exceed the amount of the co-pay

itself.

For several of the most commonly ordered laboratory tests a $1.00 co-pay would amount

to more than 30 percent of the total cost of the test.

Imposing cost sharing on clinical laboratory services will have no impact on utilization.

The patient does not initiate this use, usually has no contact with the laboratory, often

has supplemental insurance that meets the cost impact, and is unlikely to challenge the

physicians order.2

In cases where a lab does physically see a Medicare patient, many patients arehomebound or in a skilled nursing facility and likely dually eligible for Medicare and

Medicaid. In this case the lab is prohibited from billing the patient directly.

Medicare requires that beneficiaries be billed for the co-pay, no matter how small the

amount. Laboratories would bear the cost of billing, collection, and bad debt incurred

through unpaid co-pay amounts.

A new co-pay requirement for laboratory services does not save our health care system

money because it merely shifts billions in costs from the government to the nations most

vulnerable seniors.

Charging seniors a co-pay for laboratory services is at odds with demonstratedcongressional intent to encourage more prevention and early detection of chronic

diseases such as diabetes, heart disease, kidney disease, and cancer laboratory tests are

at the center of prevention and early detection.

1

Medical Laboratory Payment Policy, Institute of Medicine, 2000.2

Ibid., page 155.